6-Gingerol stabilized the p-VEGFR2/VE-cadherin/β-catenin/actin complex promotes microvessel normalization and suppresses tumor progression
Open Access
- 2 July 2019
- journal article
- research article
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 38 (1) , 1-14
Abstract
Anti-angiogenic therapies demonstrate anti-tumor effects by decreasing blood supply to tumors and inhibiting tumor growth. However, anti-angiogenic therapy may leads to changes in tumor microenvironment and increased invasiveness of tumor cells, which in turn promotes distant metastasis and increased drug resistance. The CO-IP assays, N-STORM and cytoskeleton analysis were used to confirm the mechanism that p-VEGFR2/VE-cadherin/β-catenin/actin complex regulates vascular remodeling and improves the tumor microenvironment. 6-gingerol (6G), the major bioactive component in ginger, stabilized this complex by enhancing the binding of VEGFa to VEGFR2 with non-pathway dependent. Biacore, pull down and molecular docking were employed to confirm the interaction between 6G and VEGFR2 and enhancement of VEGFa binding to VEGFR2. Here, we report that microvascular structural entropy (MSE) may be a prognostic factor in several tumor types and have potential as a biomarker in the clinic. 6G regulates the structural organization of the microvascular bed to decrease MSE via the p-VEGFR2/VE-cadherin/β-catenin/actin complex and inhibit tumor progression. 6G promotes the normalization of tumor vessels, improves the tumor microenvironment and decreases MSE, facilitating the delivery of chemotherapeutic agents into the tumor core and thereby reducing tumor growth and metastasis. This study demonstrated the importance of vascular normalization in tumor therapy and elucidated the mechanism of action of ginger, a medicinal compound that has been used in China since ancient times.Keywords
Funding Information
- National Natural Science Foundation of China (81572838, 81871972)
This publication has 40 references indexed in Scilit:
- Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapyNature Medicine, 2013
- Magnetic resonance imaging biomarkers in hepatocellular carcinoma: association with response and circulating biomarkers after sunitinib therapyJournal of Hematology & Oncology, 2013
- VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAdJournal of Experimental Medicine, 2012
- Normalization of the tumor vasculature through oncogenic inhibition: An emerging paradigm in tumor biologyProceedings of the National Academy of Sciences, 2012
- Regulation of endothelial permeability and transendothelial migration of cancer cells by tropomyosin-1 phosphorylationVascular Cell, 2012
- Vascular Endothelial Growth Factor Receptor 2 Direct Interaction with Nephrin Links VEGF-A Signals to Actin in Kidney PodocytesJournal of Biological Chemistry, 2011
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant MetastasisCancer Cell, 2009
- α2β1 integrin expression in the tumor microenvironment enhances tumor angiogenesis in a tumor cell–specific mannerBlood, 2008
- Vascular Endothelial Growth Factor Mediates Intracrine Survival in Human Breast Carcinoma Cells through Internally Expressed VEGFR1/FLT1PLOS Medicine, 2007
- The TNM staging systemGastrointestinal Endoscopy, 1996